YHLO_Clinical Solution

Autoimmune Diseases

Antibody detection is an important diagnosis tool for autoimmunity diseases.

Reproductive Health

YHLO focus on several priority areas such as increasing screening, prevention, and treatment for infections and chronic conditions before, during, and after pregnancy

Infectious Disease

YHLO can provide a unique and large panel to make differential diagnosis for respiratory disease, virus infection, blood bank.

Others

YHLO also supports a series of routine tests to meet different clinical needs.

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +